Evorel 1,6 mg/ 3,2 mg/ 4,8 mg/ 6,4 mg Transdermal patch.

Evorel 1,6 mg/ 3,2 mg/ 4,8 mg/ 6,4 mg Transdermal patch.

S4
PDF Leaflet Revision Date: 17 December 2021

API: Estradiol | Company: Adcock Ingram

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of menopausal symptoms and prevention of post-menopausal osteoporosis.

Dosage (summary)

Apply twice weekly; initiate with EVOREL 50, adjust as needed.

Special Populations

  • Elderly
  • Liver impairment
  • Kidney impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • Barbiturates
  • Carbamazepine
  • Rifampicin
  • St. John's wort
  • Lamotrigine

Contraindications

  • Hypersensitivity to estrogen
  • Breast cancer
  • Endometrial cancer
  • Undiagnosed genital bleeding
  • Active liver disease
  • Thromboembolic disorders

Common side effects

  • Headache
  • Breast pain
  • Nausea
  • Dizziness
  • Application site reactions

Counselling Points

  • Apply to clean, dry skin
  • Change patch every 3-4 days
  • Report any unusual bleeding
  • Avoid use during pregnancy

Serious warnings

  • Increased risk of breast cancer
  • Risk of thromboembolism
  • Monitor for endometrial hyperplasia

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Evorel 1,6 mg/ 3,2 mg/ 4,8 mg/ 6,4 mg Transdermal patch.
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW